Daijiworld Media Network - Washington (SD)

Washington, Mar 16: A trial funded by the National Institute of Health to evaluate a vaccine intended to protect against coronavirus (COVID 19) will conduct the first trial on Monday, according to a government official. The trial will take place at Kaiser Permanante Washingt on Health Research Institute in Seattle. Public Health officials reveal it will take nearly a year to 18 months to fully develop and validate the vaccine.

Testing will be done on 45 young and healthy volunteers on the shots developed jointly by National Institute of Health and Moderna Inc. The volunteers have no chance to be infected as the shots do not contain the virus itself health officials reveal. The vaccine intends to check that the shots do not lead to any negative side effects.

As the world is racing to contain the outbreak of the new coronavirus, some researchers are even seeking to develop temporary vaccines to give a halt to the rapid spread of the new coronavirus infection. The symptoms occur from mild cough or fever to severe symptoms as pneumonia and death for people with existing health conditions. Globally more than 1,56,000 people are affected and resulted in the death of more than 5,800 people. More than 50 people have died in the United States and around 3,000 confirmed cases across the 49 states and the District of Columbia.